Austin, Texas (PRWEB) April 30, 2012 -- ProPep Surgical, LLC. (www.propepsurgical.com), a privately-held, Austin-based medical device company, announced today it has secured the CE Mark for its ProPep Nerve Monitoring System - a family of products that allows surgeons, for the first time ever, to do intraoperative nerve monitoring during robotic surgery.
The ProPep Nerve Monitoring System is the first, real-time nerve identification system specifically designed for use during robotic surgery. Fast, accurate and easy to use, the System aids a surgeon in identifying otherwise invisible nerves during minimally invasive robotic pelvic surgery. "Currently, surgeons rely on anatomic landmarks to identify these nerves during surgery. Unfortunately, these landmarks are not always reliable," according to Dr. Randy Fagin, Chief Medical Advisor. "By helping the surgeon identify these nerves in real-time during the surgical procedure, the ProPep Nerve Monitoring System allows the surgeon to make a more informed decision about which tissue to selectively preserve or remove during an operation and as a result, potentially reduce the incidence of nerve damage related side effects such as incontinence and sexual dysfunction following prostatectomy surgery."
"Now that we have received our CE Mark, the Company will begin marketing our ProPep Nerve Monitoring System in Europe immediately," stated Jim Schneider, Chief Operating Officer. "We will be selling our System through a network of specialty medical device distributors, all with extensive experience selling into this market. ProPep will work closely with these distributors to ensure the surgeons are well versed in how to best utilize the System and how to get the most benefit from the information it provides regarding nerve location and integrity."
About ProPep Surgical, LLC
Established in 2010, ProPep Surgical is a privately-held, Austin-based medical device company developing a system of products (ProPep Nerve Monitoring System) to aid robotic surgeons in identifying otherwise invisible nerves during minimally invasive robotic surgery. Real time identification of these nerves will allow the surgeons to make a more informed decision about which tissue to selectively preserve or remove during prostatectomies, hysterectomies and colorectal surgery and as a result, potentially reduce the common side effects typically attributed to inadvertent nerve damage during these robotic surgical procedures.
Read more: http://www.sfgate.com/cgi-bin/article.cgi?f=/g/a/2012/04/30/prweb9459399.DTL#ixzz1td4MsjT2